Previous studies have demonstrated elevated CCNF expression in breast cancer 16, melanoma 24, colorectal cancer 25, gastric cancer 26, ovarian cancer 15, liver cancer 27, and pancreatic cancer 28, and g which were associated with unfavorable patient outcomes. Here, CCNF is linked to breast carcinoma.